Wendy Luo

2.5k total citations
34 papers, 823 citations indexed

About

Wendy Luo is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Ophthalmology. According to data from OpenAlex, Wendy Luo has authored 34 papers receiving a total of 823 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Pediatrics, Perinatology and Child Health and 6 papers in Ophthalmology. Recurrent topics in Wendy Luo's work include Retinal Diseases and Treatments (6 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Stress Responses and Cortisol (5 papers). Wendy Luo is often cited by papers focused on Retinal Diseases and Treatments (6 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Stress Responses and Cortisol (5 papers). Wendy Luo collaborates with scholars based in United States, Netherlands and Ireland. Wendy Luo's co-authors include Kenneth C. Cundy, Ritu Lal, Juthamas Sukbuntherng, Daniel M. Canafax, Srikonda V. Sastry, Tristen Moors, Daniel Rosebrock, Jeffrey M. Verboon, Karin Pelka and Zachary Chiang and has published in prestigious journals such as The Journal of Experimental Medicine, Nature Biotechnology and PLoS ONE.

In The Last Decade

Wendy Luo

31 papers receiving 789 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wendy Luo United States 16 262 194 181 152 110 34 823
Corinne Gérard France 20 453 1.7× 68 0.4× 131 0.7× 110 0.7× 69 0.6× 43 1.4k
Thomas Opladen Germany 24 782 3.0× 199 1.0× 62 0.3× 128 0.8× 208 1.9× 84 1.9k
Martha Carlson United States 16 279 1.1× 93 0.5× 70 0.4× 47 0.3× 182 1.7× 30 1.2k
Dong Xue Canada 12 511 2.0× 211 1.1× 153 0.8× 23 0.2× 101 0.9× 16 1.3k
Weidong Hu China 13 245 0.9× 152 0.8× 261 1.4× 50 0.3× 14 0.1× 32 691
M Tuchman United States 20 503 1.9× 94 0.5× 44 0.2× 54 0.4× 186 1.7× 52 1.1k
Gang Yu China 19 296 1.1× 110 0.6× 100 0.6× 18 0.1× 31 0.3× 72 1.0k
Xiaohong Cai China 23 562 2.1× 50 0.3× 70 0.4× 97 0.6× 50 0.5× 53 1.3k

Countries citing papers authored by Wendy Luo

Since Specialization
Citations

This map shows the geographic impact of Wendy Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy Luo more than expected).

Fields of papers citing papers by Wendy Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy Luo. The network helps show where Wendy Luo may publish in the future.

Co-authorship network of co-authors of Wendy Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy Luo. A scholar is included among the top collaborators of Wendy Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy Luo. Wendy Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Luo, Wendy, et al.. (2024). Intravitreal Metformin Protects Against Choroidal Neovascularization and Light-Induced Retinal Degeneration. International Journal of Molecular Sciences. 25(21). 11357–11357. 5 indexed citations
3.
Tulapurkar, Mohan E., Kari Ann Shirey, Wendy Luo, et al.. (2024). First-in-class mitogen-activated protein kinase (MAPK) p38α: MAPK-activated protein kinase 2 dual signal modulator with anti-inflammatory and endothelial-stabilizing properties. Journal of Pharmacology and Experimental Therapeutics. 392(3). 100031–100031. 2 indexed citations
4.
Zhang, Jason, et al.. (2023). The Emerging Role of Gut Microbiota in Age-Related Macular Degeneration. American Journal Of Pathology. 193(11). 1627–1637. 19 indexed citations
5.
Luo, Wendy & Dimitra Skondra. (2023). Implication of gut microbiome in age-related macular degeneration. Neural Regeneration Research. 18(12). 2699–2700. 7 indexed citations
6.
Wahlster, Lara, Jeffrey M. Verboon, Leif S. Ludwig, et al.. (2021). Familial thrombocytopenia due to a complex structural variant resulting in a WAC-ANKRD26 fusion transcript. The Journal of Experimental Medicine. 218(6). 10 indexed citations
7.
Lareau, Caleb A., Leif S. Ludwig, Christoph Muus, et al.. (2020). Massively parallel single-cell mitochondrial DNA genotyping and chromatin profiling. Nature Biotechnology. 39(4). 451–461. 178 indexed citations
8.
Luo, Wendy, et al.. (2020). Hypothalamic Gene Expression and Postpartum Behavior in a Genetic Rat Model of Depression. Frontiers in Behavioral Neuroscience. 14. 589967–589967. 7 indexed citations
9.
10.
Raghavan, Neha, Hao Chen, Matthew J. Schipma, et al.. (2018). Prepubertal Ovariectomy Exaggerates Adult Affective Behaviors and Alters the Hippocampal Transcriptome in a Genetic Rat Model of Depression. Frontiers in Endocrinology. 8. 373–373. 10 indexed citations
11.
Lissin, Dmitri, Wendy Luo, Katie Zomorodi, et al.. (2014). Steady State Pharmacokinetics of Formulations of XP23829, a Novel Prodrug of Monomethyl Fumarate (MMF), in Healthy Subjects (P1.188). Neurology. 82(10_supplement). 1 indexed citations
12.
Lal, Ritu, et al.. (2012). Population Pharmacokinetics and Pharmacodynamics of Gabapentin After Administration of Gabapentin Enacarbil. The Journal of Clinical Pharmacology. 53(1). 29–40. 26 indexed citations
13.
14.
Lal, Ritu, et al.. (2010). Clinical pharmacokinetic drug interaction studies of gabapentin enacarbil, a novel transported prodrug of gabapentin, with naproxen and cimetidine. British Journal of Clinical Pharmacology. 69(5). 498–507. 38 indexed citations
15.
Lal, Rattan, et al.. (2010). The effect of food with varying fat content on the clinical pharmacokinetics of gabapentin after oral administration of gabapentin enacarbil. International Journal of Clinical Pharmacology and Therapeutics. 48(2). 120–128. 17 indexed citations
16.
Zhang, Yang, et al.. (2009). New metabolites of fenofibrate in Sprague–Dawley rats by UPLC-ESI-QTOF-MS-based metabolomics coupled with LC-MS/MS. Xenobiotica. 39(4). 345–354. 16 indexed citations
17.
Gerson, Lauren B., Amine Hila, William K. Hirota, et al.. (2009). Arbaclofen Placarbil Decreases Postprandial Reflux in Patients With Gastroesophageal Reflux Disease. The American Journal of Gastroenterology. 105(6). 1266–1275. 58 indexed citations
18.
Cundy, Kenneth C., et al.. (2008). Clinical Pharmacokinetics of XP13512, a Novel Transported Prodrug of Gabapentin. The Journal of Clinical Pharmacology. 48(12). 1378–1388. 93 indexed citations
19.
20.
Acheampong, Andrew, et al.. (1995). Comparison of Concentration-Time Profiles of Levobunolol and Timolol in Anterior and Posterior Ocular Tissues of Albino Rabbits. Journal of Ocular Pharmacology and Therapeutics. 11(4). 489–502. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Corinne Gérard Breakdown of academic impact, for papers by Thomas Opladen Breakdown of academic impact, for papers by Martha Carlson Breakdown of academic impact, for papers by Dong Xue Breakdown of academic impact, for papers by Weidong Hu Breakdown of academic impact, for papers by M Tuchman Breakdown of academic impact, for papers by Gang Yu Breakdown of academic impact, for papers by Xiaohong Cai
Rankless by CCL
2026